IBB
iShares Biotechnology ETF
ICE Biotechnology TR USD
NAV as of
4 Week: 121.97 - 130.52
52 Week: 105.82 - 138.43
Latest Closing Price
126.03
Premium / Discount
-0.11
Expense Ratio
0.44%
Investment Objective
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -4.01 | 1.19 | -3.36 |
| 1 Day | 0.13 | 0.00 | 0.00 |
| 1 Week | 0.14 | 2.94 | 0.05 |
| 1 Month | -0.66 | 6.20 | -0.11 |
| 3 Months | -2.51 | 9.56 | -0.26 |
| 6 Months | 9.76 | 15.88 | 0.61 |
| 1 Year | -1.66 | 27.04 | -0.06 |
| 2 Years | -15.50 | 35.07 | -0.44 |
| 3 Years | 20.36 | 44.41 | 0.46 |
| 5 Years | 19.89 | 57.61 | 0.35 |
| 10 Years | -20.12 | 135.74 | -0.15 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 65.4713 | 34.1293 | 11.4682 | -21.5303 | 21.2011 | -9.1393 | 24.7467 | 25.9013 | 0.9906 | -13.5920 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 4.0000 | 15.0000 | 21.0000 | 92.0000 | 63.0000 | 83.0000 | 49.0000 | 39.0000 | 73.0000 | 59.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| 22/03/2023 | 28/03/2023 | 0.0646 |
| 12/12/2022 | 18/12/2022 | 0.1014 |
| 25/09/2022 | 29/09/2022 | 0.1586 |
| 08/06/2022 | 14/06/2022 | 0.0305 |
| 23/03/2022 | 29/03/2022 | 0.1176 |
| 12/12/2021 | 16/12/2021 | 0.0413 |
| 23/09/2021 | 29/09/2021 | 0.1244 |
| 09/06/2021 | 15/06/2021 | 0.0232 |
| 24/03/2021 | 30/03/2021 | 0.1311 |
| 26/03/2020 | 30/03/2020 | 0.0554 |
Portfolio Data
Total Number of Holdings: 276
Number of Bond Holdings: 0
Number of Equity Holdings: 269
Total Market Value: 7,948,191,312
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Gilead Sciences Inc | 7.4339 | 11,270,706 | 87,050 | 661,815,872 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 1.70 |
| Large | 49.02 |
| Medium | 29.32 |
| Small | 11.90 |
| Micro | 7.85 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
17.3293
Price/Book*
3.8801
Price/Sales*
3.4271
Price/Cash Flow*
14.3882
Dividend Yield*
0.6572
Growth Measures
Long-Term Earnings
8.7359
Historical Earnings
7.8294
Sales Growth
16.8996
Cash-Flow Growth
10.5885
Book-Value Growth
9.6061
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
